红色生物技术市场 - 2018-2028 年全球产业规模、份额、趋势、竞争、机会和预测，按产品类型、应用、最终用户和地区划分

在 2024-2028 年的预测期内，全球红色生物技术市场预计将以惊人的复合年增长率增长。这主要归因于对基因工程的需求不断增长、用于治疗危及生命的疾病的新药开发以及精准医疗产量的增加等因素。

基因工程需求不断增长

由于生物药物的增加，对基因工程的需求也在增加。根据 IQVIA 研究所的数据，生物药占美国所有处方药的 2%，但却占药品支出净额的 37%。基因工程（如重组 DNA 技术）在制造转基因生物（如治疗性抗体）中的应用日益广泛，推动了全球红色生物技术市场的增长。基因编辑（如基于 CRISPR 的基因编辑）等技术在市场上也越来越普遍，从而通过扩大红色生物技术在基因工程中的应用支持了市场的增长。此外，通过组织工程技术，红色生物技术还可应用于生产椎间盘、人造骨骼、皮肤和软骨。

开发治疗危及生命疾病的新药

红色生物技术可应用于基因治疗、临床试验、诊断和研究等领域。此外，为开发药物而进行的临床试验数量不断增加，以及对生物仿制药的接受度和需求的上升，也影响了红色生物技术近期的发展。随着药品生产中临床试验的不断增加，预计红色生物技术市场的生物制药领域将不断扩大。例如，2022 年 7 月，Replay - 一家基因组药物生产初创公司在种子轮融资中投资了 5500 万美元，通过开发各种基因型基因组研究的相互联系阶段来发展和改造基因组医学，从而发现新的疾病靶点，加强和改善疾病的诊断和治疗。

精准医疗产量增加

全球慢性病发病率不断上升，对精准医疗的需求也在不断增加。据世界卫生组织（WHO）统计，癌症是全球第二大死因，全球约有 960 万人死于癌症。随着全球癌症患者人数的不断增加，红色生物技术市场的增长也在不断扩大，因为它可通过基因检测和测序技术等用于诊断这些疾病的原因，从而在癌症等疾病的诊断、药物开发和治疗方面发现了许多有利可图的机会，因此预计在预测期内将促进市场增长。此外，红色生物技术还被用于联合疫苗的生产，如乙型肝炎疫苗与脊髓灰质炎疫苗的合并，以及白百破疫苗与甲型肝炎疫苗的合并，这些都对支持预测期内的市场增长具有重要意义。

最新进展

2022 年 6 月，Bluebird Bio 开发出一种新型基因疗法，该疗法正在接受美国食品药品管理局的评估，用于治疗青少年患者的脑肾上腺白质营养不良症（CALD）（一种损害脑膜髓鞘的遗传疾病）。

可定制

TechSci Research 可根据给定的市场数据，为公司的特定需求提供定制服务。报告可提供以下定制选项：

公司信息

• 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 市场覆盖范围
  • 研究年份
  • 主要市场细分

第 2 章：研究方法

• 研究目标
• 基准方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概述
• 主要市场细分概述
• 主要市场参与者概述
• 主要地区/国家概述
• 市场驱动因素、挑战和趋势概述

第 4 章：客户之声

第5章：红色生物技术市场前景。

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品类型（诊断试剂、人类疫苗、血液制品、基因重组药物及其他）
  • 按应用（生物制药生产、基因治疗、基因检测、药物基因组学、药物研发及其他）
  • 按最终用户（制药和生物技术公司、CMO 和 CRO、研究所及其他）
  • 按公司（2022 年）
  • 按地区
• 产品市场地图

第 6 章 : 亚太地区红色生物技术市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 终端用户
  • 按国家
• 亚太地区：国家分析
  • 中国 .
  • 印度 .
  • 印度 .
  • 日本
  • 澳大利亚

第 7 章 : 欧洲红色生物技术市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 终端用户
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：北美红色生物技术市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 终端用户
  • 按国家
• 北美洲：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第9章：南美洲红色生物技术市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 终端用户
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲红色生物技术市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 产品类型
  • 终端用户
  • 按国家
• 中东和非洲：国家分析
  • 南非红色生物技术
  • 沙特阿拉伯 红色生物技术
  • 阿联酋 红色生物技术
  • 科威特 红色生物技术

第 11 章 ：市场动态

• 驱动因素
• 挑战

第 12 章 ：市场趋势与发展

• 近期动态
• 合併与收购
• 产品开发

第 13 章 ：竞争格局

• 业务概述
• 公司概况
• 产品与服务
• 财务状况（上市公司）
• 近期发展
• SWOT 分析
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company Limited
  • Gilead Sciences
  • Regeneron Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche, Ltd.
  • Bruker
  • Merck KGaA
  • Celgene Corporation
  • Amgen, Inc.
  • Biogen, Inc.,

第 14 章：战略建议

Global Red Biotechnology Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as the growing demand for genetic engineering, the development of new medicines for the treatment of life-threatening diseases, and the increased production of precision medicine.

Red Biotechnology focuses on the therapeutic or diagnostic use of living cells and their components to develop novel medical treatments and cures for diseases and health issues. It includes the creation of a wide range of goods, including medicines, diagnostic instruments, vaccines, gene treatments, and other products for the treatment and prevention of different diseases.

The growing demand for precision medicine is enhancing the market opportunities and increasing demand for the global red biotechnology market.

Growing Demand for Genetic Engineering

An increase in demand for genetic engineering has been observed due to an increase in biologic drugs. According to IQVIA Institute data, biologic drugs represented 2 percent of all United States prescriptions but comprised 37% net drug spending. The growing use of genetic engineering, such as recombinant DNA technology, in creating genetically modified organisms, such as therapeutic antibodies, is propelling the growth of the red biotechnology market across the globe. The technologies, such as gene editing, such as CRISPR-based genetic editing, are also becoming much prevalent in the market and thereby are supporting the market growth by expanding the applications of red biotechnology in genetic engineering. Additionally, red biotechnology is found to have applications in the production of spinal discs, artificial bones, skin, and cartilage through tissue engineering techniques.

Development of new medicines for the treatment of life-threatening diseases

Red biotechnology has found applications in fields such as gene therapy, clinical trials, diagnostics, and research. Also, the growing number of clinical trials for the development of drugs, along with the rise in acceptance and demand for biosimilars, affect the growth of red biotechnology in the recent scenario. The expansion of the biopharmaceutical sector of the red biotechnology market is expected to grow with increasing clinical trials in medicine production. For instance, In July 2022, Replay-a genomic medicine-producing startup, invested USD55 million in a seed funding round to develop and transform genomic medicine through an interlinking stage for developing various genotype genomic research to discover new disease targets and enhance and improve the disease diagnosis & treatment.

Increased production of precision medicine

The growing prevalence of chronic diseases across the world is creating a rising demand for precision medicine. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and has recorded around 9.6 million deaths globally. With the increasing number of cancer patients worldwide, the growth of the red biotechnology market is also expanding as it is utilized for diagnosing the reason for these diseases by using genetic testing and sequencing techniques, etc., and thereby has found many lucrative opportunities in diagnosis, drug development and treatment for diseases such as cancer and is thereby expected to bolster market growth in the forecast period. Along with this, red biotechnology is utilized in combined vaccine production, such as Hepatitis B, merged with the polio vaccine, and DPT merged with Hepatitis A, and this all together is of great importance to support the market growth in the forecast period.

Recent Developments

In June 2022, Bluebird Bio developed a new gene therapy that is being evaluated by the United States Food Drug and Administration regarding the treatment of (CALD) cerebral adrenoleukodystrophy (a genetic condition that damages the membrane myelin sheath of the brain) in patients under adolescent age.

Market Segmentation

Global Red Biotechnology Market is segmented based on the product type, application, end-user, region, and competitive landscape. Based on product type, the market is segmented into diagnostic reagents, human vaccines, blood products, gene recombinant drugs, and others. Based on application, the market is segmented into biopharmaceutical production, gene therapy, genetic testing, pharmacogenomics, drug discovery, and others. Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, CMO & CRO, research institutes, and others.

Market Players

Pfizer, Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche, Ltd., Bruker, Merck KGaA, Celgene Corporation, Amgen, Inc., etc., are some of the major players operating in the Global Red Biotechnology Market.

Report Scope

In this report, Global Red Biotechnology Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Red Biotechnology Market, By Product Type:

• Diagnostic Reagents
• Human Vaccines
• Blood Products
• Gene Recombinant drugs
• Others

Red Biotechnology Market, By Application:

• Biopharmaceutical Production
• Gene Therapy
• Genetic Testing
• Pharmacogenomics
• Drug Discovery
• Others

Red Biotechnology Market, By End-User:

• Pharmaceutical and Biotechnology companies
• CMO & CRO
• Research Institute
• Others

Red Biotechnology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

• South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Red Biotechnology Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Red Biotechnology Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others)
  • 5.2.2. By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery, and Others)
  • 5.2.3. By End-User (Pharmaceutical and Biotechnology companies, CMO & CRO, Research Institute and Others)
  • 5.2.4. By Company (2022)
  • 5.2.5. By Region
• 5.3. Product Market Map

6. Asia-Pacific Red Biotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. Product Type
  • 6.2.2. End-User
  • 6.2.3. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Red Biotechnology Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. Product Type
      • 6.3.1.2.2. End-User
  • 6.3.2. India Red Biotechnology Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. Product Type
      • 6.3.2.2.2. End-User
  • 6.3.3. South Korea Red Biotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. Product Type
      • 6.3.3.2.2. End-User
  • 6.3.4. Japan Red Biotechnology Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. Product Type
      • 6.3.4.2.2. End-User
  • 6.3.5. Australia Red Biotechnology Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. Product Type
      • 6.3.5.2.2. End-User

7. Europe Red Biotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. Product Type
  • 7.2.2. End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Red Biotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. Product Type
      • 7.3.1.2.2. End-User
  • 7.3.2. Germany Red Biotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. Product Type
      • 7.3.2.2.2. End-User
  • 7.3.3. United Kingdom Red Biotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. Product Type
      • 7.3.3.2.2. End-User
  • 7.3.4. Italy Red Biotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. Product Type
      • 7.3.4.2.2. End-User
  • 7.3.5. Spain Red Biotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. Product Type
      • 7.3.5.2.2. End-User

8. North America Red Biotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. Product Type
  • 8.2.2. End-User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Red Biotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. Product Type
      • 8.3.1.2.2. End-User
  • 8.3.2. Mexico Red Biotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. Product Type
      • 8.3.2.2.2. End-User
  • 8.3.3. Canada Red Biotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. Product Type
      • 8.3.3.2.2. End-User

9. South America Red Biotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. Product Type
  • 9.2.2. End-User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Red Biotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. Product Type
      • 9.3.1.2.2. End-User
  • 9.3.2. Argentina Red Biotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. Product Type
      • 9.3.2.2.2. End-User
  • 9.3.3. Colombia Red Biotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. Product Type
      • 9.3.3.2.2. End-User

10. Middle East and Africa Red Biotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. Product Type
  • 10.2.2. End-User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Red Biotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. Product Type
      • 10.3.1.2.2. End-User
  • 10.3.2. Saudi Arabia Red Biotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. Product Type
      • 10.3.2.2.2. End-User
  • 10.3.3. UAE Red Biotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. Product Type
      • 10.3.3.2.2. End-User
  • 10.3.4. Kuwait Red Biotechnology Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. Product Type
      • 10.3.4.2.2. End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Company Snapshot
• 13.3. Products & Services
• 13.4. Financials (In case of listed companies)
• 13.5. Recent Developments
• 13.6. SWOT Analysis
  • 13.6.1. Pfizer, Inc.
  • 13.6.2. Takeda Pharmaceutical Company Limited
  • 13.6.3. Gilead Sciences
  • 13.6.4. Regeneron Pharmaceuticals, Inc.
  • 13.6.5. F. Hoffmann-La Roche, Ltd.
  • 13.6.6. Bruker
  • 13.6.7. Merck KGaA
  • 13.6.8. Celgene Corporation
  • 13.6.9. Amgen, Inc.
  • 13.6.10. Biogen, Inc.,

14. Strategic Recommendations